Integrating pre- and post-treatment Plasma Epstein-Barr Virus DNA levels for better prognostic prediction of Nasopharyngeal Carcinoma

Background: Pre- and post-treatment plasma Epstein‐Barr virus (EBV) DNA are important biomarkers for the prognosis of nasopharyngeal carcinoma (NPC). This study was performed to determine the prognostic potential of integrating EBV DNA levels in plasma measured pre-treatment (pre-EBV) and 3 months p...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Wanxia, Yang, Chao, Lv, Zehong, Li, Junzheng, Li, Zonghua, Yuan, Xiaofei, Wu, Shuting, Yuan, Yue, Cui, Linchong, Lu, Juan, Chen, Jing, Zhao, Feipeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040726/
https://www.ncbi.nlm.nih.gov/pubmed/33854631
http://dx.doi.org/10.7150/jca.56397

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040726/
https://www.ncbi.nlm.nih.gov/pubmed/33854631
http://dx.doi.org/10.7150/jca.56397

Ejemplares similares